Search research articles
Contact Us
Filters
Showing results (1-10 of 102) with videos related to
Page
of 11
Sort By:
The Journal of Clinical Psychiatry
|
June 30, 2001
Contemporary management of comorbid anxiety and depression in geriatric patients
P M Doraiswamy
The Journal of Prevention of Alzheimer'S Disease
|
May 11, 2022
Digital Therapeutics for MCI and Alzheimer's disease: A Regulatory Perspective - Highlights From The Clinical Trials on Alzheimer's Disease conference (CTAD)
J Shuren, P M Doraiswamy
Journal of the American Geriatrics Society
|
December 16, 1998
Current status of antioxidant therapy for Alzheimer's Disease
S S Pitchumoni, P M Doraiswamy
The Annals of Pharmacotherapy
|
December 1, 2000
Reboxetine: a selective norepinephrine reuptake inhibitor for the treatment of depression
A C Scates, P M Doraiswamy
JAMA
|
June 28, 2001
Relapse of depression after electroconvulsive therapy
P M Doraiswamy, A C Scates
Journal of the American Geriatrics Society
|
October 20, 1998
Combination therapy for early Alzheimer's disease: what are we waiting for?
P M Doraiswamy, D C Steffens
Journal of Geriatric Psychiatry and Neurology
|
August 14, 1999
Defining meaningful change in Alzheimer's disease trials: the donepezil experience
B M McLendon, P M Doraiswamy
Public Health Nutrition
|
March 29, 2001
Efficacy and safety of St. John's wort for the treatment of major depression
M Nangia, W Syed, P M Doraiswamy
JAMA
|
November 28, 2001
Atypical antipsychotic drugs and hyperglycemia in adolescents
E Koller, S Malozowski, P M Doraiswamy
Psychiatric Services (Washington, D.C.)
|
March 1, 1996
Advances in pharmacotherapy for decline of memory and cognition in patients with Alzheimer's disease
V Kumar, M Z Goldstein, P M Doraiswamy
Page
of 11
Search research articles
Search
Showing results (1-10 of 102) with videos related to
Sort By:
Page
of 11
The Journal of Clinical Psychiatry
|
June 30, 2001
Contemporary management of comorbid anxiety and depression in geriatric patients
P M Doraiswamy
The Journal of Prevention of Alzheimer'S Disease
|
May 11, 2022
Digital Therapeutics for MCI and Alzheimer's disease: A Regulatory Perspective - Highlights From The Clinical Trials on Alzheimer's Disease conference (CTAD)
J Shuren, P M Doraiswamy
Journal of the American Geriatrics Society
|
December 16, 1998
Current status of antioxidant therapy for Alzheimer's Disease
S S Pitchumoni, P M Doraiswamy
The Annals of Pharmacotherapy
|
December 1, 2000
Reboxetine: a selective norepinephrine reuptake inhibitor for the treatment of depression
A C Scates, P M Doraiswamy
JAMA
|
June 28, 2001
Relapse of depression after electroconvulsive therapy
P M Doraiswamy, A C Scates
Journal of the American Geriatrics Society
|
October 20, 1998
Combination therapy for early Alzheimer's disease: what are we waiting for?
P M Doraiswamy, D C Steffens
Journal of Geriatric Psychiatry and Neurology
|
August 14, 1999
Defining meaningful change in Alzheimer's disease trials: the donepezil experience
B M McLendon, P M Doraiswamy
Public Health Nutrition
|
March 29, 2001
Efficacy and safety of St. John's wort for the treatment of major depression
M Nangia, W Syed, P M Doraiswamy
JAMA
|
November 28, 2001
Atypical antipsychotic drugs and hyperglycemia in adolescents
E Koller, S Malozowski, P M Doraiswamy
Psychiatric Services (Washington, D.C.)
|
March 1, 1996
Advances in pharmacotherapy for decline of memory and cognition in patients with Alzheimer's disease
V Kumar, M Z Goldstein, P M Doraiswamy
Page
of 11